Fullerton Health Indonesia (“FHI”) joins President Joko in the launch of “Gerakan Bersama Menuju Eliminasi TBC 2030” (Elimination of Tuberculosis 2030)
FHI joined President Joko Widodo in the Ministry of Health’s launch to end tuberculosis (“TB”) in Indonesia in January 2020. The event was held in West Java, where FHI staff screened factory workers across 12 factories in West Java.
Indonesia is the second highest burden country in the world for TB, and TB is the fourth largest cause of death in the country. There are about 1m people in Indonesia who are infected with TB every year. With treatment, TB is curable, and that is why Fullerton Health advocates to help its communities screen for TB and provide access to treatment.
FHI has been active in TB screening since early 2018. Partnering with The Global Fund to Fight AIDS, Tuberculosis and Malaria, a non-profit organisation based in Geneva, FHI has been involved in serving the underserved communities across some of the major provinces in Indonesia, including Java, Sulawesi, Bali, and Kalimantan. FHI has covered a total of 278.075 people across factories, city slums, prisons, boarding schools and rural villages in the area of TB screening.
In January 2020, Fullerton also launched the “Ending Workplace TB” initiative at the World Economic Forum in Davos, together with World Economic Forum, StopTB Partnerships, The Global Fund, Johnson & Johnson and Philips.
FHI is currently involved in rolling out the Workplace TB education and screening program in partnership with Yayasan KNCV. It hopes to cover 150,000 factory workers in 250 factories in Jakarta. Any factories in the districts of North Jakarta, East Jakarta, and South Tangerang interested in being part of the free screening program are welcome to contact FHI.
